Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
28
ARSUF Quote, Financials, Valuation and Earnings
Last price:
$23.50
Seasonality move
:
-2.37%
Day range:
$23.50 - $23.50
52-week range:
$20.03 - $25.20
Dividend yield:
0%
P/E ratio:
18.40x
P/S ratio:
1.72x
P/B ratio:
6.14x
Volume:
--
Avg. volume:
--
1-year change:
17.32%
Market cap:
$1.7B
Revenue:
$943.2M
EPS (TTM):
$1.27
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Fagron NV has -- downside to fair value with a price target of -- per share.
ARSUF vs. S&P 500
-
Over the past 5 trading days, Fagron NV has underperformed the S&P 500 by -0.31% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Fagron NV does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Fagron NV has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Fagron NV reported revenues of --.
Earnings Growth
-
Fagron NV has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Fagron NV reported earnings per share of --.
Enterprise value:
2B
EV / Invested capital:
--
Price / LTM sales:
1.72x
EV / EBIT:
12.71x
EV / Revenue:
1.97x
PEG ratio (5yr expected):
0.58x
EV / Free cash flow:
27.69x
Price / Operating cash flow:
24.07x
Enterprise value / EBITDA:
9.96x
Gross Profit (TTM):
$216.3M
Return On Assets:
7.96%
Net Income Margin (TTM):
9.38%
Return On Equity:
17.38%
Return On Invested Capital:
10.32%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2010-12-31 | 2011-12-31 | 2012-12-31 | 2011-12-31 | 2012-12-31 | |
| Income Statement | ||||||
| Revenue | $561.1M | $684.5M | $702.6M | -- | $203.4M | |
| Gross Profit | $52.6M | $70.2M | $75.9M | -- | -- | |
| Operating Income | $50.5M | $65.7M | $73.2M | -- | -- | |
| EBITDA | $67.3M | $85.9M | $95.3M | -- | -- | |
| Diluted EPS | $0.92 | $1.20 | $1.69 | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $296M | $327.6M | $386.9M | $373.3M | $436.2M | |
| Total Assets | $946.1M | $1B | $1.1B | $1.1B | $1.3B | |
| Current Liabilities | $206.3M | $173.4M | $218.2M | $214.9M | $247.2M | |
| Total Liabilities | $598M | $607.4M | $634.9M | $608.8M | $719.7M | |
| Total Equity | $348.1M | $394.2M | $478.7M | $511.4M | $592.7M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-08 | 2024-12-08 | 2024-12-08 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
ARSUF
Sector
Market Cap
$1.7B
$28.5M
Price % of 52-Week High
93.25%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
0.07%
-1.33%
1-Year Price Total Return
17.32%
-20.32%
Beta (5-Year)
-0.038
0.520
Dividend yield:
0%
Annualized payout:
$0.33
Payout ratio:
-28.47%
Growth streak:
2 years
Technicals
8-day SMA
Sell
Level
$23.50
200-day SMA
Buy
Level
$22.72
Bollinger Bands (100)
Sell
Level
23.4 - 25.06
Chaikin Money Flow
Buy
Level
12.1K
20-day SMA
Sell
Level
$23.50
Relative Strength Index (RSI14)
Sell
Level
2.24
ADX Line
Sell
Level
95.55
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$23.50
MACD (12, 26)
Sell
Level
-0.02
25-day Aroon Oscillator
Sell
Level
0
On Balance Volume
Sell
Level
-25.1K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.2456)
Buy
CA Score
(Annual)
Level (0.2592)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.0777)
Buy
Piotroski F Score
(Annual)
Level (8)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. It operates through the following segments: Essentials, Brands, and Compounding Services. The Essential segment focuses on supplying raw materials to community and hospital pharmacies for pharmaceutical compounding. The Brands segment is involved in developing and producing semi-finished products and vehicles, such as emulsions, powder mixtures, creams, and other excipients, as well as total concepts and equipment for pharmaceutical compounding. The Compounding Services segment offers community and hospital pharmacies with ready-to-use non-sterile compounded medicine in those countries where it is permitted. The company was founded in 1990 and is headquartered in Nazareth, Belgium.
Stock Forecast FAQ
In the current month, ARSUF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ARSUF average analyst price target in the past 3 months is --.
-
Where Will Fagron NV Stock Be In 1 Year?
According to analysts, the consensus estimate is that Fagron NV share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Fagron NV?
Analysts are divided on their view about Fagron NV share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Fagron NV is a Sell and believe this share price will rise from its current level to --.
-
What Is Fagron NV's Price Target?
The price target for Fagron NV over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ARSUF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Fagron NV is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ARSUF?
You can purchase shares of Fagron NV via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Fagron NV shares.
-
What Is The Fagron NV Share Price Today?
Fagron NV was last trading at $23.50 per share. This represents the most recent stock quote for Fagron NV. Yesterday, Fagron NV closed at $23.50 per share.
-
How To Buy Fagron NV Stock Online?
In order to purchase Fagron NV stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ARSUF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ARSUF
Sector
P/E ratio
18.40x
23.75x
PEG ratio
0.58x
-0.01x
P/B ratio
6.14x
1.83x
Price / LTM sales
1.72x
1.60x
Growth Metrics
ARSUF
Sector
Revenue growth
--
4.85%
Earnings growth
--
11.11%
Revenue (5-year growth)
9.53%
6.45%
Earnings forecast
--
-$0.20
Profitability
ARSUF
Sector
Profitability FY 2024
$203.2M
$3.6M
Return on invested capital
10.32%
-30.98%
Return on assets
7.96%
-27.62%
Return on equity
17.38%
-36.69%
Earnings Date
Last Earnings Date
Jul
31
Next Earnings Date
Feb
12
Estimated Next Earnings Date
Oct
30
Balance Sheet
ARSUF
Sector
Total cash
$104.7M
$27.2M
Short term investments
$922K
$25.7M
Total assets
$1.1B
$79.7M
Long term debt
--
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
